scholarly journals PACIENTES SUBMETIDOS À ANGIOPLASTIA TRANSLUMINAL CORONARIANA: ANÁLISE EPIDEMIOLÓGICA E ANGIOGRÁFICA

2019 ◽  
Vol 10 (3) ◽  
Author(s):  
Tâmara Taynah Medeiros Da Silva ◽  
Rodrigo Assis Neves Dantas ◽  
Daniele Vieira Dantas ◽  
Maria Solange Moreira De Lima ◽  
Louise Constância De Melo Alves ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Educational Level ◽  
Rio Grande ◽  
Coronary Intervention ◽  
Transluminal Angioplasty ◽  
Percutaneous Coronary ◽  
Femoral Route ◽  
Male Patients ◽  
Infarto Del Miocardio

Objetivo: analisar aspectos epidemiológicos e angiográficos de pacientes submetidos à Angioplastia Transluminal Coronariana eletiva em um hospital de referência em cardiologia do estado do Rio Grande do Norte. Métodos: trata-se de uma pesquisa exploratória, descritiva, transversal com abordagem quantitativa. A coleta de dados ocorreu de abril/2017 a outubro/2017. Resultados: foram incluídos no estudo 129 pacientes, destes 65,8% eram do sexo masculino. O stent farmacológico foi mais utilizado nos procedimentos com 79 (61,2%). A via femoral predominou entre os dois sexos, com 29 (65,9%) entre mulheres e 54 (63,5%), nos homens.Conclusões:nota-se predomínio de pacientes do sexo masculino, idosos, baixo grau de escolaridade, pardos, casados e aposentados. A análise angiográfica constitui-se de pacientes com predominância de implantação de um (1) stent do tipo farmacológico, Descendente anterior e Coronária direita como coronárias tratadas, sendo a punção de acesso com maior prevalência a por via femoral.Descritores: Intervenção coronária percutânea; Angioplastia; Infarto do miocárdio; Doenças cardiovasculares; Reperfusão miocárdica.PATIENTS SUBMITTED TO CORONARY TRANSLUMINAL ANGIOPLASTY: EPIDEMIOLOGICAL AND ANGIOGRAPHIC ANALYSISObjective: to analyze epidemiological and angiographic aspects of patients submitted to elective Coronary Transluminal Angioplasty at a referral hospital in cardiology in the state of Rio Grande do Norte. Methodology: This is an exploratory, descriptive, transversal research with a quantitative approach. Data collection occurred from April / 2017 to October / 2017. Results: 129 patients were included in the study, of which 65.8% were male. The pharmacological stent was more used in the procedures with 79 (61.2%). The femoral route predominated between the two sexes, with 29 (65.9%) between women and 54 (63.5%), in men. Conclusions: a predominance of male patients, elderly, low educational level, pardos, married and retired people. Angiographic analysis consists of patients with a predominance of implantation of one (1) stent of the pharmacological type, Anterior descending and Right coronary as treated coronaries, being the access puncture with greater prevalence to the femoral route.Descriptors: Percutaneous coronary intervention, Angioplasty, Myocardial infarction, Cardiovascular diseases, Myocardial reperfusion.PACIENTES SUBMETIDOS A LA ANGIOPLASTIA TRANSLUMINAL CORONARIANA: ANÁLISIS EPIDEMIOLÓGICA Y ANGIOGRÁFICAObjetivo: analizar aspectos epidemiológicos y angiográficos de pacientes sometidos a la Angioplastia Transluminal Coronariana electiva en un hospital de referencia en cardiología del estado de Rio Grande do Norte. Metodology: setrata de una investigación exploratoria, descriptiva, transversal con abordaje cuantitativo. La recolección de datos ocurrió de abril / 2017 a octubre / 2017. Resultados: fueron incluidos en el estudio 129 pacientes, de estos 65,8% eran del sexo masculino. El stent farmacológico fue más utilizado en los procedimientos con 79 (61,2%). La vía femoral predominó entre los dos sexos, con 29 (65,9%) entre mujeres y 54 (63,5%), en los hombres. Conclusiones: se observa predominio de pacientes del sexo masculino, ancianos, bajo grado de escolaridad, pardos, casados y jubilados. análisis angiográfico consistía en pacientes con despliegue predominante de (1) el tipo stent farmacológico antes de la arteria coronaria descendente y la coronaria derecha tratada como la punción de acceso con la prevalencia más alta a través de la arteria femoral.Descriptores: Intervención coronaria percutânea; Angioplastia; Infarto del miocárdio; Enfermedades cardiovasculares; Reperfusión miocárdica.

Increasing the Penetration of Primary Angioplasty in Europe

2012 ◽  
Vol 8 (1) ◽  
pp. 60 ◽  
Author(s):  
Zuzana Kaifoszova ◽  
Petr Widimsky ◽  
◽  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Treatment Guidelines ◽  
Coronary Intervention ◽  
Reperfusion Therapy ◽  
Success Factor ◽  
The Balkans ◽  
Life Saving ◽  
Percutaneous Coronary

Primary percutaneous coronary intervention (PPCI) is recommended by the European Society of Cardiology (ESC) treatment guidelines as the preferred treatment for ST-elevation acute myocardial infarction (STEMI) whenever it is available within 90–120 minutes of the first medical contact. A survey conducted in 2008 in 51 ESC countries found that the annual incidence of hospital admissions for acute myocardial infarction is around 1,900 patients per million population, with an incidence of STEMI of about 800 per million. It showed that STEMI patients’ access to reperfusion therapy and the use of PPCI or thrombolysis (TL) vary considerably between countries. Northern, western and central Europe already have well-developed PPCI services, offering PPCI to 60–90 % of all STEMI patients. Southern Europe and the Balkans are still predominantly using TL. Where this is the case, a higher proportion of patients are left without any reperfusion treatment. The survey concluded that a nationwide PPCI strategy results in more patients being offered reperfusion therapy. To address the inequalities in STEMI patients’ access to life-saving PPCI, and to support the implementation of the ESC STEMI treatment guidelines in Europe, the Stent for Life (SFL) Initiative was launched jointly by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and EuroPCR in 2008. National cardiac societies from Bulgaria, France, Greece, Serbia, Spain and Turkey signed the SFL Declaration at the ESC Congress in Barcelona in 2009. The aim of the SFL Initiative is to improve the delivery of, and STEMI patients’ access to, life-saving PPCI and thereby reduce mortality and morbidity. Currently, 10 national cardiac societies support the SFL Initiative in their respective countries. SFL national action programmes have been developed and are being implemented in several countries. The formation of regional PPCI networks involving emergency medical services, non-percutaneous coronary intervention hospitals and PPCI centres is considered to be a critical success factor in implementing PPCI services effectively. This article describes examples of how SFL countries are progressing in implementing their national programmes, thus increasing PPCI penetration in Europe.

Optimum Therapies for ST-Elevation Myocardial Infarction Managed with Primary Percutaneous Coronary Intervention

2012 ◽  
Vol 7 (2) ◽  
pp. 81
Author(s):  
Bruce R Brodie ◽  
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Primary Percutaneous Coronary Intervention ◽  
Great Majority ◽  
Coronary Intervention ◽  
St Elevation Myocardial Infarction ◽  
Stent Deployment ◽  
Aspiration Thrombectomy ◽  
Percutaneous Coronary ◽  
St Elevation

This article reviews optimum therapies for the management of ST-elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PCI). Optimum anti-thrombotic therapy includes aspirin, bivalirudin and the new anti-platelet agents prasugrel or ticagrelor. Stent thrombosis (ST) has been a major concern but can be reduced by achieving optimal stent deployment, use of prasugrel or ticagrelor, selective use of drug-eluting stents (DES) and use of new generation DES. Large thrombus burden is often associated poor outcomes. Patients with moderate to large thrombus should be managed with aspiration thrombectomy and patients with giant thrombus should be treated with glycoprotein IIb/IIIa inhibitors and may require rheolytic thrombectomy. The great majority of STEMI patients presenting at non-PCI hospitals can best be managed with transfer for primary PCI even with substantial delays. A small group of patients who present very early, who are at high clinical risk and have long delays to PCI, may best be treated with a pharmaco-invasive strategy.

Sign in / Sign up

Export Citation Format

Share Document